485 related articles for article (PubMed ID: 12762258)
1. [Beta-blocker therapy and risk reduction in non-cardiac surgery].
Passamonti E; Pirelli S
Ital Heart J Suppl; 2003 Feb; 4(2):96-101. PubMed ID: 12762258
[TBL] [Abstract][Full Text] [Related]
2. Preoperative cardiovascular evaluation for noncardiac surgery.
Maddox TM
Mt Sinai J Med; 2005 May; 72(3):185-92. PubMed ID: 15915313
[TBL] [Abstract][Full Text] [Related]
3. Prevention of acute coronary events in noncardiac surgery: beta-blocker therapy and coronary revascularization.
Flu WJ; van Kuijk JP; Winkel T; Hoeks S; Bax J; Poldermans D
Expert Rev Cardiovasc Ther; 2009 May; 7(5):521-32. PubMed ID: 19419260
[TBL] [Abstract][Full Text] [Related]
4. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
[TBL] [Abstract][Full Text] [Related]
5. Acute peri-operative beta blockade in intermediate-risk patients.
Biccard BM; Sear JW; Foëx P
Anaesthesia; 2006 Oct; 61(10):924-31. PubMed ID: 16978304
[TBL] [Abstract][Full Text] [Related]
6. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
7. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
[TBL] [Abstract][Full Text] [Related]
8. Perioperative beta blockade in noncardiac surgery: a review of the literature.
Mason KE; Davis LL
AANA J; 2006 Apr; 74(2):113-7. PubMed ID: 16617914
[TBL] [Abstract][Full Text] [Related]
9. Perioperative beta-blocker therapy and mortality after major noncardiac surgery.
Lindenauer PK; Pekow P; Wang K; Mamidi DK; Gutierrez B; Benjamin EM
N Engl J Med; 2005 Jul; 353(4):349-61. PubMed ID: 16049209
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers and risk of all-cause mortality in non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Repaci S; del Pinto M; Gentile G; Cavallini C; Reboldi G
Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):109-18. PubMed ID: 20200201
[TBL] [Abstract][Full Text] [Related]
11. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade.
Lindenauer PK; Fitzgerald J; Hoople N; Benjamin EM
Arch Intern Med; 2004 Apr; 164(7):762-6. PubMed ID: 15078646
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?
McGory ML; Maggard MA; Ko CY
Surgery; 2005 Aug; 138(2):171-9. PubMed ID: 16153424
[TBL] [Abstract][Full Text] [Related]
13. Perioperative issues: myocardial ischemia and protection--beta-blockade.
Maggio PM; Taheri PA
Surg Clin North Am; 2005 Dec; 85(6):1091-102, viii. PubMed ID: 16326195
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis.
Talati R; Reinhart KM; White CM; Phung OJ; Sedrakyan A; Kluger J; Coleman CI
Ann Pharmacother; 2009 Jul; 43(7):1181-8. PubMed ID: 19531697
[TBL] [Abstract][Full Text] [Related]
15. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
Kaafarani HM; Atluri PV; Thornby J; Itani KM
Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
[TBL] [Abstract][Full Text] [Related]
16. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
[TBL] [Abstract][Full Text] [Related]
17. Is it time to discard beta-blockers in patients undergoing noncardiac surgery?
López-Sendón J; Alegría E
Am J Cardiovasc Drugs; 2009; 9 Suppl 1():23-6. PubMed ID: 20000885
[TBL] [Abstract][Full Text] [Related]
18. [Beta blockers reduce cardiac complications in patients undergoing surgery].
Hynynen M
Duodecim; 2000; 116(17):1805-7. PubMed ID: 12001633
[No Abstract] [Full Text] [Related]
19. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?
Poldermans D; Bax JJ; Schouten O; Neskovic AN; Paelinck B; Rocci G; van Dortmont L; Durazzo AE; van de Ven LL; van Sambeek MR; Kertai MD; Boersma E;
J Am Coll Cardiol; 2006 Sep; 48(5):964-9. PubMed ID: 16949487
[TBL] [Abstract][Full Text] [Related]
20. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
